Medical Data Vision Co., Ltd. (TYO:3902)
Japan
· Delayed Price · Currency is JPY 401.00
-13.00 (-3.14%)
Jun 6, 2025, 3:30 PM JST
Medical Data Vision Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Revenue | 6,050 | 5,906 | 6,419 | 6,104 | 5,672 | 4,579 | Upgrade
|
| Revenue Growth (YoY) | -3.17% | -7.99% | 5.16% | 7.62% | 23.87% | 13.74% | Upgrade
|
| Cost of Revenue | 1,680 | 1,576 | 1,388 | 1,075 | 1,029 | 697 | Upgrade
|
| Gross Profit | 4,370 | 4,330 | 5,031 | 5,029 | 4,643 | 3,882 | Upgrade
|
| Selling, General & Admin | 4,101 | 4,025 | 3,162 | 2,938 | 2,732 | 2,735 | Upgrade
|
| Research & Development | 290 | 290 | 68 | 332 | 316 | - | Upgrade
|
| Operating Expenses | 4,402 | 4,327 | 3,260 | 3,271 | 3,049 | 2,736 | Upgrade
|
| Operating Income | -31.47 | 3 | 1,771 | 1,758 | 1,594 | 1,146 | Upgrade
|
| Earnings From Equity Investments | -487.2 | -514 | -72 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 5.92 | 1 | 1 | -8 | -3 | 1 | Upgrade
|
| EBT Excluding Unusual Items | -511.96 | -510 | 1,700 | 1,750 | 1,591 | 1,147 | Upgrade
|
| Gain (Loss) on Sale of Investments | -127 | -127 | -15 | 51 | - | - | Upgrade
|
| Asset Writedown | -4.12 | -4 | -116 | -375 | - | -71 | Upgrade
|
| Other Unusual Items | -86 | -86 | -1 | - | -1 | - | Upgrade
|
| Pretax Income | -729.08 | -727 | 1,568 | 1,426 | 1,590 | 1,076 | Upgrade
|
| Income Tax Expense | 43.95 | 76 | 613 | 569 | 491 | 374 | Upgrade
|
| Earnings From Continuing Operations | -773.03 | -803 | 955 | 857 | 1,099 | 702 | Upgrade
|
| Minority Interest in Earnings | 10.17 | 12 | 24 | 13 | -12 | -2 | Upgrade
|
| Net Income | -762.86 | -791 | 979 | 870 | 1,087 | 700 | Upgrade
|
| Net Income to Common | -762.86 | -791 | 979 | 870 | 1,087 | 700 | Upgrade
|
| Net Income Growth | - | - | 12.53% | -19.96% | 55.29% | 26.35% | Upgrade
|
| Shares Outstanding (Basic) | 38 | 38 | 38 | 38 | 39 | 40 | Upgrade
|
| Shares Outstanding (Diluted) | 38 | 38 | 38 | 38 | 39 | 40 | Upgrade
|
| Shares Change (YoY) | -0.89% | -0.10% | -0.10% | -2.44% | -0.81% | -1.29% | Upgrade
|
| EPS (Basic) | -20.04 | -20.73 | 25.63 | 22.75 | 27.74 | 17.72 | Upgrade
|
| EPS (Diluted) | -20.04 | -20.73 | 25.63 | 22.75 | 27.74 | 17.72 | Upgrade
|
| EPS Growth | - | - | 12.64% | -17.97% | 56.55% | 28.01% | Upgrade
|
| Free Cash Flow | - | -1,031 | 1,586 | 857 | 1,058 | 938 | Upgrade
|
| Free Cash Flow Per Share | - | -27.02 | 41.52 | 22.41 | 27.00 | 23.74 | Upgrade
|
| Dividend Per Share | 6.500 | 6.500 | 6.500 | 6.000 | 5.600 | 3.600 | Upgrade
|
| Dividend Growth | - | - | 8.33% | 7.14% | 55.56% | - | Upgrade
|
| Gross Margin | - | 73.31% | 78.38% | 82.39% | 81.86% | 84.78% | Upgrade
|
| Operating Margin | -0.52% | 0.05% | 27.59% | 28.80% | 28.10% | 25.03% | Upgrade
|
| Profit Margin | -12.61% | -13.39% | 15.25% | 14.25% | 19.16% | 15.29% | Upgrade
|
| Free Cash Flow Margin | - | -17.46% | 24.71% | 14.04% | 18.65% | 20.48% | Upgrade
|
| EBITDA | 102.03 | 130 | 1,872 | 1,907 | 1,729 | 1,304 | Upgrade
|
| EBITDA Margin | - | 2.20% | 29.16% | 31.24% | 30.48% | 28.48% | Upgrade
|
| D&A For EBITDA | 133.5 | 127 | 101 | 149 | 135 | 158 | Upgrade
|
| EBIT | -31.47 | 3 | 1,771 | 1,758 | 1,594 | 1,146 | Upgrade
|
| EBIT Margin | - | 0.05% | 27.59% | 28.80% | 28.10% | 25.03% | Upgrade
|
| Effective Tax Rate | - | - | 39.09% | 39.90% | 30.88% | 34.76% | Upgrade
|
| Advertising Expenses | - | 508 | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.